(Q24794988)

English

Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling

scientific article

In more languages

Statements

scholarly article

0 references

Outcome and human epidermal growth factor receptor (HER) 1-4 status in invasive breast carcinomas with proliferation indices evaluated by bromodeoxyuridine labelling (English)

0 references

author name string

Sian M Tovey

1

0 references

Caroline J Witton

2

0 references

John M S Bartlett

3

0 references

Peter D Stanton

4

0 references

Jonathan R Reeves

5

0 references

Timothy G Cooke

6

0 references

language of work or name

0 references

publication date

2004

0 references

Breast Cancer Research

0 references

6

0 references

3

0 references

R246-51

0 references

A gene-expression signature as a predictor of survival in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

7 April 2017

Untangling the ErbB signalling network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

7 April 2017

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

7 April 2017

ErbB4 signaling in the mammary gland is required for lobuloalveolar development and Stat5 activation during lactation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

7 April 2017

Herceptin alone or in combination with chemotherapy in the treatment of HER2-positive metastatic breast cancer: pivotal trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

Prognostic and predictive value of thymidine labelling index in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

Expression of c-erbB3 protein in primary breast carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

C-erbB-3 in human breast carcinoma: expression and relation to prognosis and established prognostic indicators.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

Improved method for computing potential doubling time from flow cytometric data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

Lack of prognostic significance of DNA ploidy and S phase fraction in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

Expression of the ERBB3 gene product in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

The Clinical Significance of Epidermal Growth Factor Receptor (EGF-R) in Human Breast Cancer: A Review on 5232 Patients*

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 September 2017

The prognostic value of proliferation indices: a study with in vivo bromodeoxyuridine and Ki-67.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

30 May 2018

The ErbB signaling network in embryogenesis and oncogenesis: signal diversification through combinatorial ligand-receptor interactions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

30 May 2018

EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival.

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

21 January 2018

Expression of the HER1-4 family of receptor tyrosine kinases in breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

21 January 2018

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

21 January 2018

c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

21 January 2018

Long-term prognostic significance of thymidine labelling index in primary breast cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

21 January 2018

Relationship between EGF-R, c-erbB-2 protein expression and Ki67 immunostaining in breast cancer and hormone sensitivity.

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

21 January 2018

Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

21 January 2018

c-erbB-4/HER4: friend or foe?

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

21 January 2018

HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=400680

28 November 2018

Ribozyme-mediated down-regulation of ErbB-4 in estrogen receptor-positive breast cancer cells inhibits proliferation both in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative estimation of epidermal growth factor receptor and c-erbB-2 in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell kinetics in vivo of human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A method to measure the duration of DNA synthesis and the potential doubling time from a single sample

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB3 and c-erbB4 expression is a feature of the endocrine responsive phenotype in clinical breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical outcome and bromodeoxyuridine-derived proliferation indices in 75 invasive breast carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long-term prognostic significance of the thymidine labelling index in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of the type I growth factor receptors in a large series of human primary breast cancers quantified with a real-time reverse transcription-polymerase chain reaction assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/15084248

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of the human epidermal growth factor receptor-2 (HER2) as a prognostic marker

1 reference

https://api.crossref.org/works/10.1186%2FBCR783

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

0 references

Dimensions Publication ID

0 references

PMC publication ID

0 references

PubMed publication ID

0 references

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24794988&oldid=2175254494"